As President Donald Trump touts new deals to cut the cost of blockbuster drugs like Wegovy and Zepbound, he’s barely ...

Trump's deal slashes GLP-1 drug costs for Medicare beneficiaries and others, unlocking coverage for millions with obesity and ...

The deal is with drugmakers Eli Lilly and Novo Nordisk to cut prices of their weight-loss drugs and expand Medicare coverage ...

During the open enrollment period, it is extremely important that Medicare beneficiaries review their prescription coverage ...

The Trump administration’s pact with drugmakers to lower the price of GLP-1 drugs could pave the way for millions more to ...

Medicare enrollees looking for prescription drug coverage for the coming year may need to spend some extra time looking ...

WASHINGTON — The Trump administration is expected to announce the results of the second round of Medicare drug-price negotiations soon.

Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...

Trump announces deal with Eli Lilly, Novo Nordisk to lower cost of GLP-1 weight loss drugs Wegovy, Zepbound. Here's what to ...

Consumers will be able to buy discounted brand-name drugs through a government direct sales exchange called Trump Rx, starting in early 2026.

The reopening of the federal government has brought relief for skilled nursing providers, though key questions about reimbursement and regulatory implications still remain.